| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |